Curis LifesciencesNSE:CURIS 31 Quick Ratio is 1.28 as of Mar. 2026, which is 75% above its 10-year median of 0.73. GuruFocus rates NSE:CURIS with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 999 Drug Manufacturers companies, Curis Lifesciences ranks worse than 55.36% on this metric.
Curis Lifesciences has a quick ratio of 1.28. It generally indicates good short-term financial strength.
The historical rank and industry rank for Curis Lifesciences's Quick Ratio or its related term are showing as below:
NSE:CURIS'
s Quick Ratio Range Over the Past 10 Years
Min: 0.66 Med: 0.73 Max: 1.28
Current: 1.28
During the past 4 years, Curis Lifesciences's highest Quick Ratio was 1.28. The lowest was 0.66. And the median was 0.73.
NSE:CURIS's Quick Ratio is ranked worse than 55.36% of 999
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs NSE:CURIS: 1.28
Curis Lifesciences (NSE:CURIS) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Curis Lifesciences Quick Ratio Related Terms
Curis Lifesciences Quick Ratio Historical Data
* Premium members only.
The historical data trend for Curis Lifesciences's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences Quick Ratio Chart
Curis Lifesciences Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Quick Ratio
0.66
0.72
0.73
1.28
Curis Lifesciences Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
Quick Ratio
0.66
0.72
0.73
1.28
NSE:CURIS vs ZTS, UTHR: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curis Lifesciences Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Curis Lifesciences's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Curis Lifesciences's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences (NSE:CURIS) has a Quick Ratio of 1.28 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Curis Lifesciences and its competitors. This is 75% above median its historical median of 0.73. Over the past decade, Curis Lifesciences' Quick Ratio has ranged from 0.66 to 1.28. According to the industry distribution chart, Curis Lifesciences ranks #553 out of 999 companies in the Drug Manufacturers industry, placing it in the top 55.4%.
Is Curis Lifesciences' Quick Ratio too high?
Curis Lifesciences' current Quick Ratio of 1.28 is 75% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 1.28. The Drug Manufacturers industry median Quick Ratio is 1.45. Curis Lifesciences' value of 1.28 is 11.7% below this industry median. Based on the distribution chart, Curis Lifesciences ranks #553 out of 999 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Curis Lifesciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curis Lifesciences ranks #553 out of 999 companies for Quick Ratio. This places Curis Lifesciences in the lower half of its industry. The industry median Quick Ratio is 1.45. Curis Lifesciences' value of 1.28 is 11.7% below this benchmark. Historically, Curis Lifesciences' own Quick Ratio has ranged from 0.66 to 1.28 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 1.45, Curis Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curis Lifesciences's current Quick Ratio of 1.28 is 11.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Curis Lifesciences and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curis Lifesciences's current Quick Ratio is 1.28, which is 75% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Quick Ratio of 1.28. The current Quick Ratio is 1.28, which is 75% above median its 10-year median of 0.73 and 11.7% below the Drug Manufacturers industry median of 1.45. Curis Lifesciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Quick Ratio is 1.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
31GF Score
Get the complete analysis for NSE:CURIS
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CURIS has been successfully added to your 